Dr. Pedro R. Moreno, MD

Dr. Moreno practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Moreno's NPI, 1861414096, was assigned on July 24, 2006. Dr. Moreno graduated from Pontifical Xavierian University in 1984. Dr. Moreno holds New York license 235294.

Dr. Moreno's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Moreno also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Moreno's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Moreno to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moreno practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Moreno's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Moreno is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Moreno's licenses on file in 2 states: New York and Kentucky.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic hypertension, circulation problems, congestive heart failure and coronary artery disease among the conditions Dr. Moreno treats.

CMS data shows 513 Medicare services from Dr. Moreno across 6 procedure codes in 2024, for 210 Medicare patients. Medicare paid $34,101 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Moreno in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moreno's median patient age at 71, with 55% women.

In 2024, Dr. Moreno wrote 1,421 Medicare Part D claims for 288 patients. 89% of them were for generic drugs. CMS names the drug for 1,271 of them, across 24 drugs with 11 or more claims each, at $141,614 in total drug cost. In 2023, CMS named 561 claims across 21 drugs.

Dr. Moreno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of coronary angioplasty and stenting by Dr. Moreno, more than 46% of the clinicians it reports for that procedure.

Dmand AI links 145 papers to Dr. Moreno, published from 2002 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Coronary Artery Disease, Percutaneous Coronary Intervention and Plaque, Atherosclerotic. Dr. Moreno has published most often in J Am Coll Cardiol. Dr. Moreno's most frequent co-authors are Samin Sharma, MD, Samin Sharma, MD and Annapoorna S. Kini, MD.

Dmand AI links Dr. Moreno to 1 clinical trial. Conditions studied include Angina Pectoris and Chest Pain.

CMS Open Payments shows 538 general payments to Dr. Moreno from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 32% of the total. St. Jude Medical, Inc. paid the most, $45,596.

Dmand AI lists 3 awards for Dr. Moreno, most recently Top Doctors: New York Metro Area in 2014.

Dr. Moreno graduated from Pontifical Xavierian University in 1984. Dr. Moreno is a member of ACC.

Dr. Moreno is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.